相关实验视频
Updated: Feb 4, 2026

07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
20.1K
基于内毒素耐受性的预后模型的识别和验证,并对败血症的治疗见解进行验证
1Department of Respiratory and Critical Medicine, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Frontiers in immunology
|February 2, 2026
概括
一个新的10基因特征通过分析免疫细胞中的内毒素耐受性 (ET) 来预测败血症死亡风险. 这种ET基因 (ETG) 签名与年龄相结合,为败血症患者的短期预后提供了一个工具.
科学领域:
- 免疫学和传染病的研究
- 基因组学和生物信息学
- 关键护理医学 关键护理医学
背景情况:
- 由于从激活到免疫抑制的动态免疫转移,败血症的结果是不可预测的.
- 单细胞/巨细胞中的内毒素耐受性 (ET) 是败血症中一个关键的免疫抑制机制.
- ET尚未系统地用于败血症预后.
研究的目的:
- 开发和验证一个与内毒素耐受性相关的基因 (ETG) 签名,用于败血症死亡风险分层.
- 为改善预后,将ETG签名与临床数据 (年龄) 整合起来.
- 探索已识别的ETG的生物和治疗影响.
主要方法:
- 通过与精选的ETG基因组交叉公开的转录组数据来衍生ETG候选者.
- 采用整体机器学习框架来构建和排名28天死亡率的预后模型.
- 通过RT-qPCR,西斑和流细胞测量,验证了10基因ETG签名和年龄综合的诺米克图在潜在的ICU队列中.
主要成果:
- 10基因ETG签名表明可接受的歧视和校准预测7,14和28天死亡率 (AUCs 0.73-0.78).
- 临床队列中的未幸存者显示了关键ETG (FCGR1A,TLR5,CX3CR1) 的mRNA/蛋白水平较低,单细胞表达减少.
- 生物信息分析表明了监管轴 (NEAT1/miR-1287-5p/CX3CR1) 并确定了针对ETG的潜在候选药物.
结论:
- 一个10基因的ETG签名有效地捕捉了与败血症相关的免疫抑制,并分层了短期死亡风险.
- 综合年龄的诺姆图为预后提供了稳定的内部性能.
- 多层验证支持生物可信性,保证进一步的多中心研究和ET导向免疫调节策略的探索.
相关概念视频
Reliability and Validity
13.9K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
13.9K
Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch
7.7K
The history of therapeutic communication can be traced back to Florence Nightingale, who emphasized the importance of developing trusting relationships with patients. She taught that the presence of nurses with patients results in therapeutic healing.
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...
7.7K
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Data Validation
1.8K
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
Key parameters for method validation include:
1.8K
Data Validation
6.8K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
Nursing assessment guides are generally based on holistic models rather than medical...
6.8K
Therapeutic Index
6.8K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K

